文献速递临床试验与 GCP

腹腔镜下切除孤立性浅表腹膜型子宫内膜异位症治疗女性慢性盆腔痛的有效性(ESPriT2):多中心随机对照试验方案

Effectiveness of laparoscopic removal of isolated superficial peritoneal endometriosis for the management of chronic pelvic pain in women (ESPriT2): protocol for a multi-centre randomised controlled trial.
PubMed 文献 · Trials · 2023-06-22

本研究为多中心、参与者盲法、平行组随机对照临床与成本效果试验,计划在英国最多70家国民健康服务体系医院随机纳入400例慢性盆腔痛且拟行诊断性腹腔镜的可疑子宫内膜异位症女性。腹腔镜术中发现孤立性浅表腹膜型子宫内膜异位症且无深部或卵巢子宫内膜异位症者,术中按1:1随机分为手术切除组(切除或消融或两者兼用,按术者偏好)与仅诊断性腹腔镜组。主要结局为随机化后12个月子宫内膜异位症健康量表-30(EHP-30)疼痛域调整均值的组间比较。

要点

  • 计划从英国最多70家国民健康服务体系医院随机纳入400例慢性盆腔痛、拟行诊断性腹腔镜的可疑子宫内膜异位症女性。
  • 术中确认孤立性浅表腹膜型子宫内膜异位症且无深部或卵巢子宫内膜异位症者,按1:1随机分为手术切除组与仅诊断性腹腔镜组。
  • 主要结局为随机化后12个月EHP-30疼痛域调整均值的组间比较,假设疼痛评分标准差22分、90%把握度、5%显著性、20%缺失数据,需400例以检出8分疼痛评分差异。

核心结论

  • 本试验旨在为孤立性浅表腹膜型子宫内膜异位症的手术切除提供临床与成本效果的高质量证据。

研究设计与样本

  • 多中心、参与者盲法、平行组随机对照临床与成本效果试验,含内部预试验。
  • 计划从英国最多70家国民健康服务体系医院随机纳入400例慢性盆腔痛且拟行诊断性腹腔镜的可疑子宫内膜异位症女性。
  • 术中确认孤立性浅表腹膜型子宫内膜异位症且未见深部或卵巢子宫内膜异位症者,按1:1术中随机分为手术切除组(切除或消融或两者兼用,按术者偏好)与仅诊断性腹腔镜组,采用区组分层随机化。
  • 参与者被告知诊断,但在随机化后12个月内不知晓所接受的操作,除非有需要。
  • 术后药物治疗按参与者偏好进行;在随机化后3、6、12个月完成经验证的疼痛与生活质量问卷。

关键数值与推荐

  • 主要结局为随机化后12个月子宫内膜异位症健康量表-30(EHP-30)疼痛域,采用调整均值的随机组间比较。
  • 假设疼痛评分标准差为22分、90%把握度、5%显著性、20%缺失数据,需随机400例以检出8分疼痛评分差异。
  • 试验注册:ISRCTN注册库ISRCTN27244948,注册日期2021年4月6日。

临床怎么用

  • 原文未据此给出推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endometriosis affects 190 million women and those assigned female at birth worldwide. For some, it is associated with debilitating chronic pelvic pain. Diagnosis of endometriosis is often achieved through diagnostic laparoscopy. However, when isolated superficial peritoneal endometriosis (SPE), the most common endometriosis subtype, is identified during laparoscopy, limited evidence exists to support the common decision to surgically remove it via excision or ablation. Improved understanding of the impact of surgical removal of isolated SPE for the management of chronic pelvic pain in women is required. Here, we describe our protocol for a multi-centre trial to determine the effectiveness of surgical removal of isolated SPE for the management of endometriosis-associated pain. METHODS: We plan to undertake a multi-centre participant-blind parallel-group randomised controlled clinical and cost-effectiveness trial with internal pilot. We plan to randomise 400 participants from up to 70 National Health Service Hospitals in the UK. Participants with chronic pelvic pain awaiting diagnostic laparoscopy for suspected endometriosis will be consented by the clinical research team. If isolated SPE is identified at laparoscopy, and deep or ovarian endometriosis is not seen, participants will be randomised intraoperatively (1:1) to surgical removal (by excision or ablation or both, according to surgeons' preference) versus diagnostic laparoscopy alone. Randomisation with block-stratification will be used. Participants will be given a diagnosis but will not be informed of the procedure they received until 12 months post-randomisation, unless required. Post-operative medical treatment will be according to participants' preference. Participants will be asked to complete validated pain and quality of life questionnaires at 3, 6 and 12 months after randomisation. Our primary outcome is the pain domain of the Endometriosis Health Profile-30 (EHP-30), via a between randomised group comparison of adjusted means at 12 months. Assuming a standard deviation of 22 points around the pain score, 90% power, 5% significance and 20% missing data, 400 participants are required to be randomised to detect an 8-point pain score difference. DISCUSSION: This trial aims to provide high quality evidence of the clinical and cost-effectiveness of surgical removal of isolated SPE. TRIAL REGISTRATION: ISRCTN registry ISRCTN27244948. Registered 6 April 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mackenzie SC, Stephen J, Williams L, et al. Effectiveness of laparoscopic removal of isolated superficial peritoneal endometriosis for the management of chronic pelvic pain in women (ESPriT2): protocol for a multi-centre randomised controlled trial. Trials. 2023. PMID: 37349849. doi:10.1186/s13063-023-07386-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。